semaglutide kidney disease FDA Approves to Reduce Disease, Cardiovascular Death Risk in Adults With Type 2 Diabetes, Chronic Kidney Long-term kidney outcomes of semaglutide

You will meet with one of our physicians or RNs for a consult

iThriveMD is a longevity clinic focused on proactive aging, cellular health, and metabolic performance

We recommend parking for free at the Fair Plaza Garage, only a 2-minute walk from the clinic

Regul Pept 167(23):177184 Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, Zelber-Sagi S, Wai-Sun Wong V, Dufour J-F, Schattenberg JM, Kawaguchi T, Arrese M, Valenti L, Shiha G, Tiribelli C, Yki-Jrvinen H, Fan J-G, Grnbk H, Yilmaz Y, Cortez-Pinto H, Oliveira CP, Bedossa P, Adams LA, Zheng M-H, Fouad Y, Chan W-K, Mendez-Sanchez N, Ahn SH, Castera L, Bugianesi E, Ratziu V, George J (2020) A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

Take control of your health today and experience sustainable weight loss by completing your online evaluation with Klinic

Sofwave: restoring tension in the mid-dermis Sofwave delivers focused ultrasound energy 1.5 mm into the dermis, stimulating fibroblasts to produce collagen and elastin